April 30, 2020 Glenmark Pharmaceuticals announced that it has received the Drugs Controller General (I) permission to conduct clinical trial on Favipiravir. As on date, Glenmark is the first pharmaceutical company in India to be given an approval by…
Recent Post
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
- Drug Applications with Unanswered Queries to Be Rejected Within 30 Days by CDSCO
- ⚖️ “No Approval, No Market”: Delhi High Court Sends a Strong Message on Unapproved Drugs & FDCs
